KEWAUNEE SCIENTIFIC CORPORATION
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $282.0M | $240.5M | $203.8M | $219.5M | $168.9M | $147.5M | $147.5M | $146.6M |
| Cost of Revenue | $201.6M | $171.6M | $151.7M | $183.9M | $144.7M | $123.5M | $124.1M | $121.2M |
| Gross Profit | $80.4M | $68.9M | $52.1M | $35.6M | $24.2M | $24.0M | $23.4M | $25.3M |
| Gross Margin | 28.5% | 28.6% | 25.5% | 16.2% | 14.3% | 16.3% | 15.9% | 17.3% |
| Operating Expenses | ||||||||
| Research & Development | $898.0K | $919.0K | $920.0K | $1.0M | $990.0K | $1.4M | $1.8M | $1.6M |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $16.7M | $17.8M | $18.3M | $5.4M | $-2.6M | $-1.3M | $-2.3M | $2.1M |
| Operating Margin | 5.9% | 7.4% | 9.0% | 2.4% | -1.5% | -0.9% | -1.6% | 1.4% |
| Interest Expense | — | — | $1.8M | $1.7M | $632.0K | $389.0K | $493.0K | $367.0K |
| Pretax Income | $13.7M | $14.8M | $13.1M | $4.5M | $-2.5M | $-2.6M | $-2.9M | $2.1M |
| Income Tax Expense | $3.3M | $3.2M | $-5.9M | $3.1M | $3.5M | $990.0K | $1.8M | $446.0K |
| Net Income | $9.6M | $11.4M | $18.8M | $738.0K | $-6.1M | $-3.7M | $-4.7M | $1.5M |
| Net Margin | 3.4% | 4.7% | 9.2% | 0.3% | -3.6% | -2.5% | -3.2% | 1.0% |
| EPS (Basic) | $3.36 | $3.98 | $6.51 | $0.26 | $-2.20 | $-1.33 | $-1.70 | $0.56 |
| EPS (Diluted) | $3.22 | $3.83 | $6.38 | $0.25 | $-2.20 | $-1.33 | $-1.70 | $0.55 |
| Shares Outstanding (Basic) | 2.9M | 2.9M | 2.9M | 2.8M | 2.8M | 2.8M | 2.8M | 2.7M |
| Shares Outstanding (Diluted) | 3.0M | 3.0M | 2.9M | 2.9M | 2.8M | 2.8M | 2.8M | 2.8M |
| Dividends Per Share | — | — | — | — | — | — | $0.38 | $0.74 |